Furthermore, the treatment of primary hepatocytes bearing PNPLA3 rs738409 (148M variant) results in lipid reduction, consistent with the alleviation of PNPLA3 148M-induced steatosis. This evidence concerns the gene PNPLA3 and steatosis.